Manufacturing HGS infrastructure is designed to produce an abundance of pre-clinical therapeutic protein candidates, each from a newly described gene and purified protein. We now have the facilities and staff to produce several grams of each protein for pre-clinical testing. We have also initiated the process to construct a pilot plant to produce clinical grade material for our medical trials. Revenue from Corporate Partnerships HGS has created a broad network of corporate partnerships to provide substantial near, intermediate, and long-term revenue to support our internal drug discovery effort. One or more of the collaborators products may enter clinical trials as early as 1997.
Classical microscopes magnify human tissues and cells.